ARA-290
Non-haematopoietic EPO analogue that activates the Innate Repair Receptor (IRR) for tissue protection, pain reduction, and anti-inflammatory effects without
Buy more, save more
Total Price
$85
For research & laboratory use only. Not for human consumption.
Half-Life
~1-2 hours
Administration Route
Subcutaneous injection
Innate Repair Receptor
Activates tissue-protective EPO receptor without erythropoiesis
Neuropathic Pain
Reduces small fibre neuropathy in sarcoidosis patients — RCT data
Anti-Inflammatory
Suppresses macrophage M1 polarisation without immunosuppression
Effect Profile
Immune Activation
Anti-Viral Defence
Inflammation Control
Immune Ageing
Mechanism of Action
Scientific Research
Proc Natl Acad Sci USA (2010)
Mol Med (2014)
Mol Endocrinol (2012)
Product FAQs
Stacks Well With
BPC-157
Body Protection Compound 157 accelerates healing of tendons, ligaments, muscle, and gut tissue through angiogenesis and growth factor upregulation.
Thymosin Alpha-1 (Ta1)
FDA-designated immunomodulator (Zadaxin) approved in 35+ countries for hepatitis B, hepatitis C, and cancer immunotherapy. Activates T-cells and dendritic
LL-37
Human cathelicidin antimicrobial peptide with broad-spectrum antibacterial, antiviral, and antifungal activity. Also promotes wound healing and modulates
Related Products
EPO (Erythropoietin)
Recombinant erythropoietin that stimulates red blood cell production, increasing oxygen-carrying capacity. Extensively researched for anaemia, renal disease
Thymosin Alpha-1 (Ta1)
FDA-designated immunomodulator (Zadaxin) approved in 35+ countries for hepatitis B, hepatitis C, and cancer immunotherapy. Activates T-cells and dendritic
BPC-157
Body Protection Compound 157 accelerates healing of tendons, ligaments, muscle, and gut tissue through angiogenesis and growth factor upregulation.